WHO
-
WHO gives new recommendations for screening and treatment of cervical cancer as decline in screening of breast and cervical cancer witnessed
SWITZERLAND – World Health Organization (WHO) and Human Reproduction Programme (HRP) have launched new guidelines to help countries make faster progress, more and equitably, on…
-
World Health Organization commits to advocate for women empowerment and health
SWITZERLAND – Following the General Equality Forum held last week in France, the world Health Organization (WHO) pledged it would commit to drive change for…
-
WHO and Global Fund sign cooperation agreement to scale up HIV, TB and Malaria treatment
AFRICA – The World Health Organization and the Global Fund to Fight AIDS, Tuberculosis and Malaria have signed a cooperation and financing agreement to implement…
-
Coronavirus is spreading in Africa at record pace, WHO warns, as vaccine shipments trickle in
AFRICA – The Delta variant of coronavirus is driving the pandemic forward in Africa at record speeds, the World Health Organization (WHO) has cautioned. Infection…
-
Gilead files with the US Food and Drug Administration for approval of its HIV drug lenacapavir
US – The American biopharmaceutical company, Gilead Sciences has filed its investigational long -acting HIV therapy, lencapavir with the US Food and Drug Administration (USFDA)…
-
‘War room’ task force convenes to discuss ways on how to help fight COIVD-19 pandemic in developing states
GENEVA – Heads of the World Bank Group (WBG), International Monetary Fund (IMF), World Health organization (WHO) and World Trade organization (WTO) had their first…
-
Inadequate financing threatens Ghana’s universal health coverage
GHANA – Ghana’s quest to attain the World Health Organization’s Universal Health Coverage (UHC) by 2030 set to suffer a setback if the government does…
-
Emergex’s dengue vaccine candidate receives regulatory approval for its first phase clinical trial
UK – A company tackling major global infectious disease threats through the development of 100% synthetic ‘set point’ vaccines, Emergex Vaccines Holding has received regulatory…
-
Lilly’s tirzepatide tops list ahead of ozempic as treatment candidate for type 2 diabetes
US – In the just concluded phase 3 trials, the American pharmaceutical company, Eli Lilly have provided results that showed its investigational Gastric inhibitory polypeptide…
-
‘Mix match’ COVID-19 vaccine approach under consideration following promising results
UK – The UK based Com-Cov study, involving trial usage of two different COVID-19 vaccines, that began early this year has brought back positive with…